HFM
MYGN icon

Hartford Financial Management’s Myriad Genetics MYGN Stock Holding History

Hartford Financial Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$343 Hold
60
– – ﹤0.01% 344
2026
Q1 		$270 Hold
60
– – ﹤0.01% 340
2025
Q4 		$369 Hold
60
– – ﹤0.01% 331
2025
Q3 		$434 Hold
60
– – ﹤0.01% 332
2025
Q2 		$319 Hold
60
– – ﹤0.01% 341
2025
Q1 		$533 Hold
60
– – ﹤0.01% 350
2024
Q4 		$823 Hold
60
– – ﹤0.01% 368
2024
Q3 		$1.64K Hold
60
– – ﹤0.01% 367
2024
Q2 		$1.47K Buy
+60
New +$1.32K ﹤0.01% 369

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hartford Financial Management's MYGN Position: Q2 2026 in Review

Hartford Financial Management held its Myriad Genetics (MYGN) position steady in Q2 2026 at 60 shares worth $343. The position accounts for ﹤0.01% of the portfolio, ranked #344.

Hartford Financial Management first reported a position in MYGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.64K in Q3 2024. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Hartford Financial Management held 60 shares of Myriad Genetics worth $343 as of Q2 2026.
  • Hartford Financial Management left its Myriad Genetics share count unchanged in Q2 2026.
  • Myriad Genetics made up ﹤0.01% of Hartford Financial Management's portfolio in Q2 2026, its #344 holding.
  • Hartford Financial Management first reported a position in Myriad Genetics in Q2 2024 and has held it in 9 quarters since.
  • Hartford Financial Management's Myriad Genetics position peaked at $1.64K in Q3 2024.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Hartford Financial Management's 13F filing for Q2 2026, filed 24 Jul 2026.